Low clinical adoption of tumor genomic profiling: cause for concern?
- PMID: 29708449
- PMCID: PMC6062854
- DOI: 10.1080/13696998.2018.1470978
Low clinical adoption of tumor genomic profiling: cause for concern?
Comment on
-
Real-world utilization of molecular diagnostic testing and matched drug therapies in the treatment of metastatic cancers.J Med Econ. 2018 Jun;21(6):543-552. doi: 10.1080/13696998.2017.1423488. Epub 2018 Jan 19. J Med Econ. 2018. PMID: 29295635
Similar articles
-
Fidelity and deceit at the bedside.JAMA. 2000 Apr 12;283(14):1881-4. doi: 10.1001/jama.283.14.1881. JAMA. 2000. PMID: 10770152 No abstract available.
-
Precision Medicine.Health Aff (Millwood). 2018 May;37(5):687. doi: 10.1377/hlthaff.2018.0520. Health Aff (Millwood). 2018. PMID: 29733714 Review. No abstract available.
-
Ideal and Reality: The Gap Between Evidence Derived From Randomized Controlled Trial-Based Meta-analysis and Real-World Clinical Practice in Antidepressant Strategy for Depression.J Clin Psychopharmacol. 2020 Jul/Aug;40(4):428-429. doi: 10.1097/JCP.0000000000001231. J Clin Psychopharmacol. 2020. PMID: 32639301 No abstract available.
-
Diffusion and Use of Tethered Personal Health Records in Primary Care.Perspect Health Inf Manag. 2015 Apr 1;12(Spring):1c. eCollection 2015. Perspect Health Inf Manag. 2015. PMID: 26755897 Free PMC article.
-
Personalised Healthcare: The DiMA Clinical Model.Curr Pharm Biotechnol. 2017;18(3):242-252. doi: 10.2174/1389201018666170208125131. Curr Pharm Biotechnol. 2017. PMID: 28183244 Review.
References
-
- Druker BJ, Tamura S, Buchdunger E, et al. Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 1996;2:561–6 - PubMed
-
- Jänne PA, Yang JC, Kim DW, et al. AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer. N Engl J Med 2015;372:1689–99 - PubMed
-
- Kim G, Ison G, McKee AE, et al. FDA approval summary: olaparib monotherapy in patients with deleterious germline BRCA-mutated advanced ovarian cancer treated with three or more lines of chemotherapy. Clin Cancer Res 2015;21:4257–61 - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources